MedPath

Comparison of Hemodynamic Effects of Two Modalities of Alveolar Recruitment Maneuvers in Major Abdominal Surgery Patients

Not Applicable
Completed
Conditions
Decreased Cardiac Output
Hemodynamic Monitoring
Cardiac Output
Blood Pressure
Stroke Volume
Major Abdominal Surgery
Mechanical Ventilation
Hemodynamic Optimization
Interventions
Procedure: alveolar recruitment maneuver
Registration Number
NCT05365113
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

The objective of this study is to investigate the hemodynamic effects of two strategies of alveolar recruitment maneuver in patients undergoing major abdominal surgery in the operating room

Detailed Description

In practice, after induction of general anesthesia and intubation, patients will be conditioned with the recommended monitoring (arterial catheter, central venous catheter, and transpulmonary thermodilution).

Once conditioning is complete, optimization of blood volume will be performed with volumetric expansions (250 mL of Ringer lactate) to achieve a change in stroke volume of less than 10%, as recommended (RFE SFAR 2013 - Perioperative Vascular Filling Strategy). The patient will then be randomized to one of the following groups: \[ extended sigh then CPAP \] or \[ CPAP then extended sigh \] (random order of ARMs - each patient becoming their own control). In order to homogenize the settings, the mechanical ventilation will be standardized with in particular the use of a PEEP of 6 cmH2O before inclusion and between the ARMs (for a duration of at least 10 minutes in each case).

Hemodynamic values will be recorded during the last 10 seconds of each procedure. Once the two ARMs have been performed, the rest of the management will then be left to the discretion of the practitioner in charge of the patient.

The included patient will be managed according to the recommendations at the time of the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • patient over 18 years old
  • patient under general anesthesia
  • patient intubated under controlled invasive mechanical ventilation
  • patient with invasive hemodynamic monitoring (transpulmonary thermodilution)
  • patient sedated (BIS between 40 and 60) and/or curarized with TOF monitoring to avoid inspiratory effort
  • patient optimized on the hemodynamic level, in particular with regard to blood volume, following the hemodynamic monitoring data and the recommendations of the French Society of Anesthesia and Resuscitation (RFE SFAR 2013 - Perioperative vascular filling strategy)
  • patient covered by a Social Security plan
  • patient consent to participate in the study
Exclusion Criteria
  • contraindication to the use of cardiac output measurement
  • cardiac arrhythmia
  • pace-maker/implantable defibrillator
  • severe valvulopathy
  • contraindication to the use of the tomographic electroimpedancemetry technique
  • thoracic lesions, thoracic dressing
  • left ventricular ejection fraction (LVEF) < 45% and/or right ventricular failure.
  • history of pulmonary lobectomy and/or pneumonectomy and/or known emphysema
  • patient with restrictive or obstructive lung disease
  • body mass index (BMI) < 16.5 or > 30 kg.m-2
  • pregnancy
  • intracranial hypertension or suspected intracranial hypertension
  • patient under limitation of care
  • patient under legal protection (guardianship, curatorship, safeguard of justice)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Continuous positive airway pressure (CPAP) then extended sighalveolar recruitment maneuverPatients assigned to this group will receive a CPAP ARM (40cmH2O during 50 seconds), followed by a 10-minute pause corresponding to a period of return to basal state. Then an ARM by extended sigh (e-sigh) also 50 seconds (driving pressure at 10cmH2O and successive PEEP levels at 10, 15, 20, 25 and 30cmH2O, with respiratory frequency fixed at 30/min in controlled pressure). Hemodynamic (blood pressure, cardiac output, stroke volume) and ventilatory measurements will be performed the last 10 seconds of each recruitment maneuver.
extended sigh then continuous positive airway pressure (CPAP)alveolar recruitment maneuverPatients assigned to this group will receive an ARM by extended sigh (e-sigh) during 50 seconds (driving pressure at 10cmH2O and successive PEEP levels at 10, 15, 20, 25 and 30cmH2O, with respiratory frequency fixed at 30/min in controlled pressure), followed by a 10-minute pause corresponding to a period of return to basal state. Then they receive a CPAP ARM (40cmH2O during 50 seconds). Hemodynamic (blood pressure, cardiac output, stroke volume) and ventilatory measurements will be performed the last 10 seconds of each recruitment maneuver.
Primary Outcome Measures
NameTimeMethod
The primary outcome measure is the change in cardiac output during the last 10 seconds of each MRA modality from its baseline value (determined after hemodynamic optimization and before the procedure was performed)last 10 seconds of each ARM modality

Cardiac output (l/min) will be measured by invasive monitoring during the last 10 seconds of each recruitment maneuver

Secondary Outcome Measures
NameTimeMethod
Invasive hemodynamic monitoring datalast 10 seconds of each ARM modality

change in stroke volume

Standard hemodynamic monitoring datalast 10 seconds of each ARM modality

heart rate

Evaluation of standard ventilatory monitoring datalast 10 seconds of each ARM modality

compliance of the respiratory system

Paraclinics datalast 10 seconds of each ARM modality

During the last 10 seconds of the recruitment maneuver, SpO2 will be recorded

Electro-impedancemetry datalast 10 seconds of each ARM modality

Analysis of pulmonary aeration will be performed using the non-invasive technique of tomographic electroimpedancemetry with the placement of an electrode belt on the patient's chest. Values will be recorded with this belt :

percentages of overdistended and atelectasis areas

Trial Locations

Locations (1)

CHU

🇫🇷

Clermont-Ferrand, France

© Copyright 2025. All Rights Reserved by MedPath